Combined activity of azithromycin and lansoprazole against Helicobacter pylori

Helicobacter

Volumn 4, Issue 2, 1999, Pages 113-120

  Trautmann, Matthias ^a   Riediger, Christine ^a   Möricke, Angelika ^a   Vogt, Konstanze ^b   Bohr, Ulrich ^a,c   Glasbrenner, Bernhard ^a,c  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; ANTIINFECTIVE AGENT; AZITHROMYCIN; DRUG DERIVATIVE; LANSOPRAZOLE; OMEPRAZOLE; PROTON PUMP;

ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; DRUG SYNERGISM; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MICROBIAL SENSITIVITY TESTS; OMEPRAZOLE; PROTON PUMPS;

EID: 0033142666     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-5378.1999.98045.x     Document Type: Article

References (19)

1. Marshall BJ. Helicobacter pylori. Am J Gastroenterol 1994;89 (Suppl.):S116-S128.
2. Malfertheiner P, and the European Helicobacter Pylori Study Group. Current consensus concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 1997; 41:8-13.
3. Tytgat GNJ. Peptic ulcer and Helicobacter pylori: Eradication and relapse. Scand J Gastroenterol 1995; 30 (Suppl. 210):70-2.
4. Bazzoli F. Therapy of H. pylori infection. J Physiol Pharmacol 1997;48 (Suppl. 4):39-44.
5. Lind T, Veldhuyzen van Zanten SJO, Unge P, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: The MACH1 study. Helicobacter 1996;1:138.
6. Peters DH, Friedel HA, McTavish D. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy. Drugs 1992;44:750-99.
7. Harrison JD, Jones JA, Morris DL. Azithromycin levels in plasma and gastric tissue, juice and mucus. Eur J Clin Microbiol Infect Dis 1991;10:862-4.
8. Mégraud F, Darmaillac V, Brugmann D. Helicobacter pylori and azithromycin. Pathol Biol 1995; 43:555-60..
9. Iwahi T, Satoh H, Nakao M, et al. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicrob Agents Chemother 1991;35:490-6.
10. Figura N, Crabtree JE, Dattilo M. In-vitro activity of lansoprazole against Helicobacter pylori. J Antimicrob Chemother 1997;39:585-90.
11. Petite JP, Slama JL, Licht H, et al. Comparison of lansoprazole (30 mg) and omeprazole (20 mg) in the treatment of duodenal ulcer. A multicenter double-blind comparative trial. Gastroenterol Clin Biol 1993;17:334-40.
12. Spinzi GC, Bierti L, Bortoli A, et al. Comparison of omeprazole and lansoprazole in short-term triple therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1998;12:443-8.
13. Goodwin S. Detection of H. pylori by biopsy urease, histology, and culture. In: Helicobacter pylori Protocols: Methods in Molecular Medicine (Vol. 8), Clayton CL, Mobley HLT, eds. Totowa, NJ: Humana Press, 1997; 7-18.
14. Simor AE, Ferro S, Low DE. Comparative in vitro activities of six new fluoroquinolones and other oral antimicrobial agents against Campylobacter pylori. Antimicrob Agents Chemother 1989;33: 108-9.
15. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standard (3rd edn). NCCLS Document M7-A3, Vol. 13 (25). Villanova, PA, 1993.
16. Elipoulos GM, Moellering RC Jr. Antimicrobial combinations. In: Antibiotics in Laboratory Medicine (3rd edn) Lorian V, ed. Baltimore: Williams & Wilkins, 1991;432-92.
17. Olivier R, Bugnoli M, Armellini D, et al. Growth of Helicobacter pylori in media containing cyclodextrins. J Clin Microbiol 1993;31:160-2.
18. Hardy DJ, Hanson CW, Hensey DM, Beyer JM, Fernandes PB. Susceptibility of Campylobacter pylori to macrolides and fluoroquinolones. J Antimicrob Chemother 1988;22:631-6.
19. Midolo PD, Turnidge JD, Lambert JR. Bactericidal activity and synergy studies of proton pump inhibitors and antibiotics against Helicobacter pylori in vitro. J Antimicrob Chemother 1997;39:331-7.